 |
cell based therapeutic composed of allogeneic donor apoptotic cells |
|---|---|
| Trade Name | Apocell |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2013-03-18 00:00:00 |
| Sponsor | Enlivex Therapeutics Ltd.;POB 12167, Hadassah Ein Kerem;Jerusalem |
